DAPSA, DAS28 and MDA predict long-term treatment regime in psoriatic arthritis. The Swedish Early Psoriatic Arthritis Cohort.

MLA

Lindqvist, Ulla, et al. “DAPSA, DAS28 and MDA Predict Long-Term Treatment Regime in Psoriatic Arthritis. The Swedish Early Psoriatic Arthritis Cohort.” Clinical and Experimental Rheumatology, vol. 35, no. 6, Nov. 2017, pp. 936–42. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=28628468&authtype=sso&custid=ns315887.

APA

Lindqvist, U., Wernroth, M.-L., Husmark, T., Larsson, P., Geijer, M., Teleman, A., Theander, E., & Alenius, G.-M. (2017). DAPSA, DAS28 and MDA predict long-term treatment regime in psoriatic arthritis. The Swedish Early Psoriatic Arthritis Cohort. Clinical and Experimental Rheumatology, 35(6), 936–942.

Chicago

Lindqvist, Ulla, Mona-Lisa Wernroth, Tomas Husmark, Per Larsson, Mats Geijer, Annika Teleman, Elke Theander, and Gerd-Marie Alenius. 2017. “DAPSA, DAS28 and MDA Predict Long-Term Treatment Regime in Psoriatic Arthritis. The Swedish Early Psoriatic Arthritis Cohort.” Clinical and Experimental Rheumatology 35 (6): 936–42. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=28628468&authtype=sso&custid=ns315887.